ML NK cells can ignore signals from some inhibitory receptors [inhibitory killer Ig-like receptors (iKIR)], and exhibit increased expression of the activating receptors NKG2D, DNAM-1, and NKp46 (21, 23), suggesting that they may be effective in recognizing additional tumor types, such as melanoma. The gene discussed is CD226; the disease is melanoma.